Dipna Pharmachem Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: January 22, 2025, 10:56 pm

Market Cap	36.1 Cr.
Current Price	15.0
High / Low	16.4/6.40
Stock P/E	43.5
Book Value	15.8
Dividend Yield	0.00 %
ROCE	7.05 %
ROE	3.52 %
Face Value	10.0
PEG Ratio	-1.08

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Dipna Pharmachem Ltd

Competitors of Dipna Pharmachem Ltd

Stock Name	Market Cap	Current Price	High / Low	Stock P/E	Book Value	Dividend Yield	ROCE	ROE	Face Value
MPS Pharmaa Ltd	8.01 Cr.	4.19	4.33/2.92		0.80	0.00 %	9.15 %	34.9 %	10.0
Gujarat Themis Biosyn Ltd	3,436 Cr.	315	390/189	65.2	20.5	0.21 %	45.0 %	33.8 %	1.00
Gujarat Terce Laboratories Ltd	57.4 Cr.	77.4	94.9/27.0	22.0	11.9	0.00 %	9.72 %	3.44 %	10.0
Gujarat Inject (Kerala) Ltd	38.1 Cr.	26.0	27.5/8.74	49.4	6.64	0.00 %	2.65 %	2.08 %	10.0
Godavari Drugs Ltd	80.9 Cr.	107	155/87.0	12.1	55.4	0.00 %	14.4 %	15.5 %	10.0
Industry Average	18,260.52 Cr	1,126.57		52.81	184.98	0.33%	16.18%	16.43%	6.27

All Competitor Stocks of Dipna Pharmachem Ltd

Quarterly Result

Month	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024
Sales	29	44	49	74	74	90	91
Expenses	28	42	48	73	73	88	89
Operating Profit	1	1	1	2	2	2	1
OPM %	3%	3%	2%	2%	2%	2%	2%
Other Income	-0	0	-0	-0	-0	-0	-0
Interest	0	0	0	1	1	1	1
Depreciation	-0	-0	-0	0	0	0	-0
Profit before tax	0	1	0	1	1	1	0
Tax %	25%	26%	26%	27%	27%	21%	26%
Net Profit	0	1	0	1	1	0	0
EPS in Rs	33.00	84.00	0.13	0.24	0.24	0.20	0.14

Last Updated: January 5, 2025, 8:17 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

Month	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	17	20	30	31	73	100	164
Expenses	16	20	30	31	71	98	161
Operating Profit	0	0	0	0	2	2	3
OPM %	2%	2%	1%	1%	3%	2%	2%
Other Income	0	0	0	0	0	0	0
Interest	0	0	0	0	1	1	2
Depreciation	0	0	0	0	0	0	0
Profit before tax	0	0	0	0	2	1	1
Tax %	14%	40%	0%	60%	26%	34%	24%
Net Profit	0	0	0	0	1	1	1
EPS in Rs	6.00	3.00	6.00	2.00	117.00	0.37	0.45
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2022-2023	2023-2024
YoY Net Profit Growth (%)	0.00%	0.00%
Change in YoY Net Profit Growth (%)	0.00%	0.00%

Dipna Pharmachem Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 2 years from 2022-2023 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	52%
3 Years:	74%
TTM:	22%

Compounded Profit Growth
10 Years:	%
5 Years:	105%
3 Years:	279%
TTM:	-30%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	49%

Return on Equity
10 Years:	%
5 Years:	7%
3 Years:	7%
Last Year:	4%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 1:50 pm

Month	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	0.04	0.04	0.04	0.04	0.04	12	24	24
Reserves	0	0	1	1	2	12	13	14
Borrowings	5	6	10	12	10	16	19	17
Other Liabilities	6	8	8	12	24	37	76	78
Total Liabilities	11	14	18	25	36	78	133	133
Fixed Assets	0	0	0	0	0	0	0	0
CWIP	0	0	0	0	0	0	0	0
Investments	0	0	0	0	0	0	0	0
Other Assets	11	14	18	25	36	78	133	133
Total Assets	11	14	18	25	36	78	133	133

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	-3	-2	3	-21	-5
Cash from Investing Activity +	0	-0	-0	-0	-0
Cash from Financing Activity +	3	2	-3	26	14
Net Cash Flow	0	0	-0	5	8

Free Cash Flow

Month	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-5.00	-6.00	-10.00	-12.00	-8.00	-14.00	-16.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	132	160	134	176	135	104	69
Inventory Days	112	66	70	89	34	72	86
Days Payable	142	148	105	145	123	139	172
Cash Conversion Cycle	103	78	99	120	46	38	-17
Working Capital Days	116	114	119	150	59	126	96
ROCE %		8%	5%	3%	17%	9%	7%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024
Promoters	66.56%	66.56%	57.19%	9.98%	9.98%
Public	33.45%	33.43%	42.81%	90.02%	90.02%
No. of Shareholders	1,110	992	1,078	1,807	2,652

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	0.90	260.55	333.40	6.91	16.86
Diluted EPS (Rs.)	0.90	260.55	333.40	6.91	16.86
Cash EPS (Rs.)	0.45	0.77	335.17	8.97	19.37
Book Value[Excl.RevalReserv]/Share (Rs.)	15.60	20.35	496.74	163.34	156.41
Book Value[Incl.RevalReserv]/Share (Rs.)	15.60	20.35	496.74	163.34	156.41
Revenue From Operations / Share (Rs.)	68.34	83.48	20787.26	8857.11	8725.29
PBDIT / Share (Rs.)	1.43	1.96	644.23	118.66	92.26
PBIT / Share (Rs.)	1.42	1.95	642.46	116.60	89.75
PBT / Share (Rs.)	0.59	1.15	449.80	15.71	17.15
Net Profit / Share (Rs.)	0.45	0.76	333.40	6.91	16.86
PBDIT Margin (%)	2.08	2.35	3.09	1.33	1.05
PBIT Margin (%)	2.07	2.33	3.09	1.31	1.02
PBT Margin (%)	0.86	1.38	2.16	0.17	0.19
Net Profit Margin (%)	0.66	0.91	1.60	0.07	0.19
Return on Networth / Equity (%)	2.89	3.74	67.11	4.23	10.78
Return on Capital Employeed (%)	6.82	6.06	44.39	9.58	57.38
Return On Assets (%)	0.81	1.17	3.22	0.09	0.32
Long Term Debt / Equity (X)	0.33	0.58	1.91	6.44	0.00
Total Debt / Equity (X)	0.51	0.65	5.86	21.74	17.45
Asset Turnover Ratio (%)	1.56	1.76	2.38	1.43	1.88
Current Ratio (X)	1.60	1.99	1.16	1.21	1.03
Quick Ratio (X)	1.15	1.50	0.95	0.85	0.71
Inventory Turnover Ratio (X)	0.00	0.00	10.03	4.90	0.00
Interest Coverage Ratio (X)	1.72	2.46	3.34	1.18	1.27
Interest Coverage Ratio (Post Tax) (X)	1.54	1.95	2.73	1.07	1.23
Enterprise Value (Cr.)	28.22	25.24	0.00	0.00	0.00
EV / Net Operating Revenue (X)	0.17	0.25	0.00	0.00	0.00
EV / EBITDA (X)	8.22	10.74	0.00	0.00	0.00
MarketCap / Net Operating Revenue (X)	0.13	0.15	0.00	0.00	0.00
Price / BV (X)	0.60	0.61	0.00	0.00	0.00
Price / Net Operating Revenue (X)	0.13	0.15	0.00	0.00	0.00
EarningsYield	0.04	0.06	0.00	0.00	0.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Dipna Pharmachem Ltd as of January 23, 2025 is: 24.68

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of January 23, 2025, Dipna Pharmachem Ltd is Undervalued by 64.53% compared to the current share price 15.00

Intrinsic Value of Dipna Pharmachem Ltd as of January 23, 2025 is: 14.70

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of January 23, 2025, Dipna Pharmachem Ltd is Overvalued by 2.00% compared to the current share price 15.00

Last 5 Year EPS CAGR: -40.43%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has shown consistent growth in sales (62.14 cr) and profit (0.57 cr) over the years.	The stock has a low average ROCE of 7.00%, which may not be favorable. The stock has a high average Working Capital Days of 111.43, which may not be favorable. The stock has a high average Cash Conversion Cycle of 66.71, which may not be favorable. The company has higher borrowings (11.88) compared to reserves (5.38), which may suggest financial risk.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Dipna Pharmachem Ltd:
1. Net Profit Margin: 0.66%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 6.82% (Industry Average ROCE: 16.05%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 2.89% (Industry Average ROE: 15.89%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 1.54
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.15
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 43.5 (Industry average Stock P/E: 42.77)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.51
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Dipna Pharmachem Ltd. is a Public Limited Listed company incorporated on 19/07/2011 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24100GJ2011PLC066400 and registration number is 066400. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 164.34 Cr. and Equity Capital is Rs. 24.05 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad Gujarat 380055	info@dipnapharmachem.com http://www.dipnapharmachem.com

Management
Name	Position Held
Mr. Keyur Dipakkumar Shah	Managing Director
Ms. Dipna Keyur Shah	Non Executive Director
Mr. Nandish Shaileshbhai Jani	Independent Director
Mr. Jitendra Pradipbhai Parmar	Independent Director

FAQ

What is the latest intrinsic value of Dipna Pharmachem Ltd?

The latest intrinsic value of Dipna Pharmachem Ltd as on 23 January 2025 is ₹24.68, which is 64.53% higher than the current market price of ₹15.00. The stock has a market capitalization of 36.1 Cr. and recorded a high/low of 16.4/6.40 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹14 Cr and total liabilities of ₹133 Cr.

What is the Market Cap of Dipna Pharmachem Ltd?

The Market Cap of Dipna Pharmachem Ltd is 36.1 Cr..

What is the current Stock Price of Dipna Pharmachem Ltd as on 23 January 2025?

The current stock price of Dipna Pharmachem Ltd as on 23 January 2025 is 15.0.

What is the High / Low of Dipna Pharmachem Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Dipna Pharmachem Ltd stocks is 16.4/6.40.

What is the Stock P/E of Dipna Pharmachem Ltd?

The Stock P/E of Dipna Pharmachem Ltd is 43.5.

What is the Book Value of Dipna Pharmachem Ltd?

The Book Value of Dipna Pharmachem Ltd is 15.8.

What is the Dividend Yield of Dipna Pharmachem Ltd?

The Dividend Yield of Dipna Pharmachem Ltd is 0.00 %.

What is the ROCE of Dipna Pharmachem Ltd?

The ROCE of Dipna Pharmachem Ltd is 7.05 %.

What is the ROE of Dipna Pharmachem Ltd?

The ROE of Dipna Pharmachem Ltd is 3.52 %.

What is the Face Value of Dipna Pharmachem Ltd?

The Face Value of Dipna Pharmachem Ltd is 10.0.